Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Psychopharmacology (Berl)
.
2024 Nov;241(11):2405.
doi: 10.1007/s00213-024-06666-x.
Authors
Michael C Mithoefer
1
,
Allison A Feduccia
2
,
Lisa Jerome
3
,
Anne Mithoefer
4
,
Mark Wagner
1
,
Zach Walsh
5
,
Scott Hamilton
6
,
Berra Yazar-Klosinski
7
,
Amy Emerson
3
,
Rick Doblin
7
Affiliations
1
Medical University of South Carolina, Charleston, SC, USA.
2
MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA. alli@mapsbcorp.com.
3
MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA.
4
Private Practice, Charleston, SC, USA.
5
University of British Columbia-Okanagan, Kelowna, BC, Canada.
6
Stanford School of Medicine, Stanford University, Stanford, CA, USA.
7
Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA.
PMID:
39126501
PMCID:
PMC11513733
DOI:
10.1007/s00213-024-06666-x
No abstract available
Publication types
Retraction of Publication